Good news! Beijing Jinhao Pharmaceutical has been selected for the first batch of Beijing municipal enterprise technology centers in 2022.
Release time：2022.10.24
Recently, Beijing Jinhao Pharmaceutical Co., Ltd. (referred to as "Jinhao Pharmaceutical") was selected for the "First Batch of Beijing Municipal Enterprise Technology Centers in 2022." A total of 96 enterprises were successfully selected this time, including 15 enterprises from Beijing Economic-Technological Development Area, among which Jinhao Pharmaceutical is one.
The recognition of enterprise technology centers is a high-value R&D platform qualification granted by the Beijing municipal government to enterprises with strong technological innovation capabilities, significant innovation achievements, and important demonstration and guiding roles. The establishment of enterprise technology centers is an important approach by the Beijing Municipal Bureau of Economy and Information Technology to promote the development of high-end industries and to discover and cultivate more exemplary enterprises with strong innovation capabilities and good innovation mechanisms.
Jinhao Pharmaceutical's inclusion in this list reflects the Beijing municipal government's high recognition of our company's scientific research level and technological innovation capabilities. In the biopharmaceutical and health industry chain, Jinhao Pharmaceutical will continue to work hard, persist in technological innovation, enhance the competitiveness of the company and its products, and contribute to regional industrial innovation and economic development!
Copyright © 2025 Beijing Kinghawk Pharmaceutical Co., Ltd. All rights reserved.